Immunocore
Immunocore is an England-based biotechnology company that develops and commercializes biological therapies for the treatment of cancer.
Business Model:
Revenue: $122M
Employees: 201-500
Industries / Tags:
Detailed Immunocore Information
Geographic Data
Address: 92 Park Drive, Milton Park
City: Abingdon
State: england
Zip: OX14 4RY
Country: GB
Financial Info
Stage:
post ipo equity
Raised Last:
$140M
Raised Total:$809M
Social
Metrics
105,945Website Global Rank
838,602Website Monthly Traffic
Twitter Followers
Description
Immunocore is an England-based biotechnology company that develops and commercializes biological therapies for the treatment of cancer.
Contact Phone:
Contact Email:
Immunocore went public on 2/4/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/4/2021
IPO Valuation:
$1B
Ticker Symbol:
IMCR
IPO Price:
$26/share
Amount Raised:
$258M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
